Thrombin Activable Fibrinolysis Inhibitor (TAFI): Molecular Genetics of an Emerging Potential Risk Factor for Thrombotic Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-5895|1|2|59-74

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.1, Iss.2, 2001-12, pp. : 59-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombin-activatable fibrinolysis inhibitor in kidney transplant recipient with dyslipidemia

By Malyszko J. Malyszko J.S. Hryszko T. Mysliwiec M.

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2219-2221

Elsevier

Access to resources Recommend Favorite

Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin‐ activatable fibrinolysis inhibitor

International Journal Of Laboratory Hematology, Vol. 37, Iss. 4, 2015-08 ,pp. : 521-529

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platelet polymorphisms in thrombotic disorders

By Santoso S.

Transfusion Clinique et Biologique, Vol. 8, Iss. 3, 2001-06 ,pp. : 261-266

Elsevier

Access to resources Recommend Favorite

Effects of Hirudin (Thrombin Specific Inhibitor) in Zebrafish Embryos: A Developmental Role for Thrombin

By Jagadeeswaran P. Liu Y.C. Eddy C.A.

Blood Cells, Molecules, and Diseases, Vol. 23, Iss. 3, 1997-12 ,pp. : 410-414

Academic Press

Access to resources Recommend Favorite

Vitamin D deficiency as a risk factor for allergic disorders and immune mechanisms

By Frieri Marianne Valluri Ashok

Allergy and Asthma Proceedings, Vol. 32, Iss. 6, 2011-11 ,pp. : 438-444

OceanSide Publications, Inc

Access to resources Recommend Favorite